Host: |
Rabbit/Rabbit |
Applications: |
ELISA |
Reactivity: |
Human |
Note: |
FOR SCIENTIFIC EDUCATIONAL RESEARCH USE ONLY (RUO). MUST NOT BE USED IN DIAGNOSTIC OR OTHER MEDICAL APPLICATIONS. |
Short Description: |
This POSTN/OSF-2 antibody pair contains complimentary capture and detection antibodies, which work together under the principals of the Sandwich ELISA. |
Clonality: |
Polyclonal/Polyclonal |
Conjugation: |
Unconjugated/Biotin |
Formulation: |
Capture Buffer: PBS with 0.04% Proclin 300, 50% glycerol, pH 7.4.Detection Buffer: PBS with 0.04% Proclin 300, 50% glycerol, pH 7.4. |
Purification: |
Capture Purification: Protein A & Antigen Affinity.Detection Purification: Protein A & Antigen Affinity. |
Concentration: |
0.5 mg/mL |
Storage Instruction: |
Store at-20°C for long term, and avoid freeze-thaw cycles. |
Gene Symbol: |
POSTN |
Gene ID: |
10631 |
Uniprot ID: |
POSTN_HUMAN |
Immunogen: |
Capture immunogen: Recombinant Human POSTN/OSF-2 protein.Detection Immunogen: Recombinant Human POSTN/OSF-2 protein. |
Post Translational Modifications | Gamma-carboxylation is controversial. Gamma-carboxyglutamated.gamma-carboxyglutamate residues are formed by vitamin K dependent carboxylation.this may be required for calcium binding. According to a more recent report, does not contain vitamin K-dependent gamma-carboxyglutamate residues. |
Function | Induces cell attachment and spreading and plays a role in cell adhesion. Enhances incorporation of BMP1 in the fibronectin matrix of connective tissues, and subsequent proteolytic activation of lysyl oxidase LOX. |
Protein Name | PeriostinPnOsteoblast-Specific Factor 2Osf-2 |
Cellular Localisation | Golgi ApparatusSecretedExtracellular SpaceExtracellular MatrixColocalizes With Bmp1 In The Golgi |
Alternative Antibody Pair Names | Periostin antibody pairPn antibody pairOsteoblast-Specific Factor 2 antibody pairOsf-2 antibody pairPOSTN antibody pairOSF2 antibody pair |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance